Table of Content 1 Industry Overview 1.1 Metastatic Ovarian Cancer Drug Industry 1.1.1 Overview 1.1.2 Products of Major Companies 1.2 Market Segment 1.2.1 Industry Chain 1.2.2 Consumer Distribution 1.3 Price & Cost Overview 2 Metastatic Ovarian Cancer Drug Market by Type 2.1 By Type 2.1.1 E-7449 2.1.2 Crizotinib 2.1.3 CMB-305 2.1.4 G-305 2.1.5 LV-305 2.1.6 Others 2.2 Market Size by Type 2.3 Market Forecast by Type 3 Global Market Demand 3.1 Segment Overview 3.1.1 Clinic 3.1.2 Hospital 3.1.3 Others 3.2 Market Size by Demand 3.3 Market Forecast by Demand 4 Major Region Market 4.1 Global Market Overview 4.1.1 Market Size & Growth 4.1.2 Market Forecast 4.2 Major Region 4.2.1 Market Size & Growth 4.2.2 Market Forecast 5 Major Companies List 5.1 Adgero Biopharmaceuticals Inc (Company Profile, Sales Data etc.) 5.2 Cellceutix Corporation (Company Profile, Sales Data etc.) 5.3 Eisai Co., Ltd. (Company Profile, Sales Data etc.) 5.4 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.) 5.5 Immune Design Corp. (Company Profile, Sales Data etc.) 5.6 Millennium Pharmaceuticals Inc (Company Profile, Sales Data etc.) 5.7 MolMed S.p.A. (Company Profile, Sales Data etc.) 5.8 Natco Pharma Limited (Company Profile, Sales Data etc.) 5.9 Northwest Biotherapeutics, Inc. (Company Profile, Sales Data etc.) 5.10 Pfizer Inc. (Company Profile, Sales Data etc.) 5.11 Richter Gedeon Nyrt. (Company Profile, Sales Data etc.) 5.12 Sumitomo Dainippon Pharma Co., Ltd. (Company Profile, Sales Data etc.) 5.13 VG Life Sciences, Inc. (Company Profile, Sales Data etc.) 6 Conclusion

Table Global Metastatic Ovarian Cancer Drug Market 2015-2018, by Type, in USD Million Table Global Metastatic Ovarian Cancer Drug Market 2015-2018, by Type, in Volume Table Global Metastatic Ovarian Cancer Drug Market Forecast 2019-2025, by Type, in USD Million Table Global Metastatic Ovarian Cancer Drug Market Forecast 2019-2025, by Type, in Volume Table Adgero Biopharmaceuticals Inc Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Adgero Biopharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cellceutix Corporation Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Cellceutix Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Eisai Co., Ltd. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table F. Hoffmann-La Roche Ltd. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Immune Design Corp. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Immune Design Corp. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Millennium Pharmaceuticals Inc Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Millennium Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table MolMed S.p.A. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of MolMed S.p.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Natco Pharma Limited Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Natco Pharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Northwest Biotherapeutics, Inc. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Northwest Biotherapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Pfizer Inc. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Richter Gedeon Nyrt. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Richter Gedeon Nyrt. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Sumitomo Dainippon Pharma Co., Ltd. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of Sumitomo Dainippon Pharma Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table VG Life Sciences, Inc. Overview List Table Metastatic Ovarian Cancer Drug Business Operation of VG Life Sciences, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Figure Global Metastatic Ovarian Cancer Drug Market Growth 2015-2018, by Type, in USD Million Figure Global Metastatic Ovarian Cancer Drug Market Growth 2015-2018, by Type, in Volume